在X相关的低酸性血症中肠道病变的发病率:一项探索性超声波研究
Lisa Bachfischer1,2,3, Martina Behanova1,2,3, Eva Rath2
1Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK, 1140 Vienna, Austria.
JBMR plus
|August 13, 2025
概括
影响肌插入的肠道病变在X结合性低血症 (XLH) 中很常见,影响了运动能力. 超声波显示高患病率,随着年龄的增长而增加,并且与XLH患者的身体功能减少有关.
科学领域:
- 整形外科 整形外科 整形外科
- 遗传学 是一个遗传学.
- 类风湿病学 类风湿病学
背景情况:
- 与X相关的低酸血症 (XLH) 是一种罕见的遗传疾病,导致酸盐浪费和骨矿化缺陷.
- 静脉病,一种影响肌插入的疾病,是XLH成年人的未被认可的症状,影响生活质量.
研究的目的:
- 用超声波来确定XLH患者中肠道病变的患病率.
- 评估XLH患者中肠道病变与疼痛,身体功能和人口因素之间的关联.
主要方法:
- 一项涉及26名XLH患者 (平均年龄37.9岁) 的横截面研究.
- 16个肌 (上肢和下肢) 的超声检查.
- 评估身体功能 (6分钟的步行测试,椅子上升测试) 和疼痛 (简要的疼痛清单).
主要成果:
- 在84.6%的XLH患者中检测到肠道病变,通常影响下肢 (80.8%),主要影响四头四和阿基里斯肌.
- 肠病发病率随年龄增加 (r=0.61,p<.05) 并与6分钟步行测试的表现负相关 (r=-0.4,p=.04).
- 在肠道病变和BMI或疼痛得分之间没有发现显著的关联; 73.1%的人报告轻度疼痛.
结论:
- 肠道病变是XLH患者上肢和下肢的共同特征.
- 肠道病变的存在与流动性减少相关,突显了针对性干预的需要.
- 年龄是XLH中肠病发病率的一个重要因素,尽管潜在的机制需要进一步调查.
相关概念视频
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...